These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11421246)

  • 21. The effect of dairy product ingestion on human immunodeficiency virus-related diarrhea in a sample of predominantly gay men: a randomized, controlled, double-blind, crossover trial.
    Tinmouth J; Kandel G; Tomlinson G; Walmsley S; Steinhart AH; Glazier R
    Arch Intern Med; 2006 Jun; 166(11):1178-83. PubMed ID: 16772244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triple-class antiretroviral drug resistance: risk and predictors among HIV-1-infected patients.
    Napravnik S; Keys JR; Quinlivan EB; Wohl DA; Mikeal OV; Eron JJ
    AIDS; 2007 Apr; 21(7):825-34. PubMed ID: 17415037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infection.
    Kaufmann GR; Khanna N; Weber R; Perrin L; Furrer H; Cavassini M; Ledergerber B; Vernazza P; Bernasconi E; Rickenbach M; Hirschel B; Battegay M;
    Antivir Ther; 2004 Apr; 9(2):263-74. PubMed ID: 15134189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
    Ortega KL; Vale DA; Magalhães MH
    J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diarrhea in children less than two years of age with known HIV status in Kisumu, Kenya.
    van Eijk AM; Brooks JT; Adcock PM; Garrett V; Eberhard M; Rosen DH; Ayisi JG; Ochieng JB; Kumar L; Gentsch JR; Nahlen BL; Mintz ED; Slutsker L
    Int J Infect Dis; 2010 Mar; 14(3):e220-5. PubMed ID: 19664950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term virological outcome and resistance mutations at virological rebound in HIV-infected adults on protease inhibitor-sparing highly active antiretroviral therapy.
    de la Rosa R; Ruíz-Mateos E; Rubio A; Abad MA; Vallejo A; Rivero L; Genebat M; Sánchez-Quijano A; Lissen E; Leal M
    J Antimicrob Chemother; 2004 Jan; 53(1):95-101. PubMed ID: 14657091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.
    Laurichesse JJ; Persoz A; Theodorou I; Rouzioux C; Delfraissy JF; Meyer L
    HIV Med; 2007 May; 8(4):213-9. PubMed ID: 17461848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mortality due to liver failure and impact on survival of hepatitis virus infections in HIV-infected patients receiving potent antiretroviral therapy.
    Macías J; Melguizo I; Fernández-Rivera FJ; García-García A; Mira JA; Ramos AJ; Rivera JM; Pineda JA
    Eur J Clin Microbiol Infect Dis; 2002 Nov; 21(11):775-81. PubMed ID: 12461586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteonecrosis in six HIV-infected patients receiving highly active antiretroviral therapy.
    Molia AC; Strady C; Rouger C; Beguinot IM; Berger JL; Trenque TC
    Ann Pharmacother; 2004 Dec; 38(12):2050-4. PubMed ID: 15507502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and impact of diarrhea on health-related quality of life in HIV-infected patients in the era of highly active antiretroviral therapy.
    Siddiqui U; Bini EJ; Chandarana K; Leong J; Ramsetty S; Schiliro D; Poles M
    J Clin Gastroenterol; 2007; 41(5):484-90. PubMed ID: 17450031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study.
    Omland LH; Weis N; Skinhøj P; Laursen A; Christensen PB; Nielsen HI; Møller A; Engsig F; Sørensen HT; Obel N
    HIV Med; 2008 May; 9(5):300-6. PubMed ID: 18400077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virus.
    Nguyen ST; Eaton SA; Bain AM; Rahman AP; Payne KD; Bedimo R; Herrington JD; Maclayton DO; Rodriguez-Barradas MC; Busti AJ
    Pharmacotherapy; 2008 Mar; 28(3):323-30. PubMed ID: 18294112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The incidence of and risk factors for HIV-associated cognitive-motor complex among patients on HAART.
    Jevtović Dj; Vanovac V; Veselinović M; Salemović D; Ranin J; Stefanova E
    Biomed Pharmacother; 2009 Sep; 63(8):561-5. PubMed ID: 19026516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of highly active antiretroviral therapy (HAART) in a cohort of patients with HIV infection in Mexico].
    Jáuregui Camargo L; Ruiz-Palacios G; Guerrero Almeida L; Niño Oberto S; Peasey A; Sierra Madero J
    Rev Invest Clin; 2003; 55(1):10-7. PubMed ID: 12708158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of protease inhibitors on the outcome of human immunodeficiency virus-infected patients with chronic diarrhea.
    Bini EJ; Cohen J
    Am J Gastroenterol; 1999 Dec; 94(12):3553-9. PubMed ID: 10606318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endoscopic evaluation of chronic human immunodeficiency virus-related diarrhea: is colonoscopy superior to flexible sigmoidoscopy?
    Bini EJ; Weinshel EH
    Am J Gastroenterol; 1998 Jan; 93(1):56-60. PubMed ID: 9448175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV and diarrhea in the era of HAART: 1998 New York State hospitalizations.
    Anastasi JK; Capili B
    Am J Infect Control; 2000 Jun; 28(3):262-6. PubMed ID: 10840348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intestinal malabsorption of HIV-infected children: relationship to diarrhoea, failure to thrive, enteric micro-organisms and immune impairment. The Italian Paediatric Intestinal/HIV Study Group.
    AIDS; 1993 Nov; 7(11):1435-40. PubMed ID: 8280408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.